ePoster

All ePoster presentations will be available to view anytime throughout the Meeting in an Online Library

Title:

Intraocular foreign bodies in the anterior segment of the eye

Poster Details

First Author: M. Stamenkovic SERBIA

Co Author(s):    Z. Zikic   N. Nikitovic   A. Popovic   J. Milic   D. Timotijevic   M. Popovic     

Abstract Details

Purpose:

To investigate clinical characteristics and visual outcomes of intraocular foreign body in the anterior segment of the eye.

Setting:

Eye Clinic, University Medical Center Zvezdara, Belgrade, Serbia

Methods:

Consecutive series of 7 eyes with IOFB located in the anterior segment presented at the Eye Clinic, UniversityMedical Center Zvezdara from 2014 to 2019. Preoperative status and management of injuries were collected retrospectively. The material and location were recorded of all cases.

Results:

The average patient age was 55.3 years with male predominance (6 male patients, and 1 female). The most frequent injury mechanism was hammering 5 eyes, and the composition of IOFB was metallic in 5 cases . Initial VA was less then 0.1 in 5 eyes , 0.1-0.4 in 1 eye and 0.5 and more in 1 eye. Final BCVA was less then 0.1 in 2 eyes, 0.1-0.4 in 2 eyes and 0,5 and more in 3 eyes. Complications were hypopion in 1 eye, cataract in 7 eyes, vitreous haemorrhage in 2 eyes and hyphaema in 2 eyes.

Conclusions:

Initial VA generally is one of the most important prognostic factors for predicting final visual outcome after IOFB in the anterior segment of the eye. Other factors which may predict final vision are size of the wound, location of the wound and the development of complications.

Financial Disclosure:

gains financially from competing product or procedure, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, is employed by a competing company, has significant investment interest in a company producing, developing or supplying product or procedure presented